Financials Wellell Inc.

Equities

4106

TW0004106000

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
27.8 TWD +0.36% Intraday chart for Wellell Inc. +1.28% -3.81%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,472 2,452 2,901 2,967 2,967 2,916
Enterprise Value (EV) 1 2,216 2,322 2,709 2,914 2,917 2,522
P/E ratio 20.9 x 27.9 x 27.9 x 29.1 x 18.5 x 19.3 x
Yield 2.65% 1.85% 1.91% 1.87% 2.89% -
Capitalization / Revenue 1.17 x 1.2 x 1.45 x 1.25 x 1.11 x 1.1 x
EV / Revenue 1.05 x 1.14 x 1.35 x 1.23 x 1.1 x 0.95 x
EV / EBITDA 11.5 x 11.3 x 15.4 x 14.9 x 10.6 x 8.85 x
EV / FCF -24.6 x 19 x 15 x -25.7 x -70.6 x 6.64 x
FCF Yield -4.06% 5.27% 6.68% -3.89% -1.42% 15.1%
Price to Book 1.22 x 1.21 x 1.38 x 1.44 x 1.34 x 1.25 x
Nbr of stocks (in thousands) 100,912 100,912 100,912 100,912 100,912 100,912
Reference price 2 24.50 24.30 28.75 29.40 29.40 28.90
Announcement Date 3/29/19 3/31/20 3/31/21 3/31/22 3/31/23 3/15/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,106 2,036 2,004 2,374 2,664 2,647
EBITDA 1 193.1 205.8 175.8 195.5 275.6 284.8
EBIT 1 136.8 128.8 98.94 104.3 184.9 194.2
Operating Margin 6.5% 6.32% 4.94% 4.39% 6.94% 7.34%
Earnings before Tax (EBT) 1 150.3 128.4 124.8 138.1 200.5 209.9
Net income 1 108.4 87.92 104.6 102.2 161.4 152.2
Net margin 5.15% 4.32% 5.22% 4.31% 6.06% 5.75%
EPS 2 1.174 0.8700 1.030 1.010 1.590 1.500
Free Cash Flow 1 -89.94 122.4 181 -113.3 -41.3 379.5
FCF margin -4.27% 6.01% 9.03% -4.77% -1.55% 14.34%
FCF Conversion (EBITDA) - 59.49% 102.96% - - 133.23%
FCF Conversion (Net income) - 139.25% 173.04% - - 249.39%
Dividend per Share 2 0.6500 0.4500 0.5500 0.5500 0.8500 -
Announcement Date 3/29/19 3/31/20 3/31/21 3/31/22 3/31/23 3/15/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 256 130 192 52.8 50 395
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -89.9 122 181 -113 -41.3 380
ROE (net income / shareholders' equity) 6.02% 4.38% 5.1% 4.96% 7.55% 6.7%
ROA (Net income/ Total Assets) 2.99% 2.61% 2.04% 2.11% 3.65% 3.77%
Assets 1 3,632 3,368 5,131 4,851 4,425 4,032
Book Value Per Share 2 20.00 20.10 20.80 20.40 22.00 23.10
Cash Flow per Share 2 4.430 4.160 4.660 4.890 4.410 6.430
Capex 1 171 30.9 46.3 46.7 45 28.8
Capex / Sales 8.12% 1.52% 2.31% 1.97% 1.69% 1.09%
Announcement Date 3/29/19 3/31/20 3/31/21 3/31/22 3/31/23 3/15/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4106 Stock
  4. Financials Wellell Inc.